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Abstract: Current evidence indicates an inverse association between Helicobacter pylori and 
asthma and allergy. H. pylori is a Gram-negative bacterium which represents the major cause 
of peptic ulcer and gastric cancer, and preferentially elicits a T helper (Th)-1 response. Many 
H. pylori factors, such as the neutrophil-activating factor of H. pylori (HP-NAP), are able to 
drive Th-1 polarization and to display a powerful inhibition of allergic Th-2 response. This 
article proposes an overview of the actual knowledge about the effects of H. pylori on asthma 
and allergy. Special attention has been drawn to HP-NAP as a potential novel strategy for the 
prevention and treatment of asthma and atopy.
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Introduction
The prevalence of airway allergic disease such as asthma has over the years increased 
in developed countries. The causes of this increase remain largely unknown. Proposed 
associations include changes in smoking habits,1 exposure to food-borne and orofecal 
infections,2,3 types of dwellings,4 ownership of furry animals,5 number of siblings, 
family income/education level,6 and the presence of particulates in diesel exhaust.7 
The inverse association between family size and manifestations of allergy has been 
consistently found,8–11 and there is also a much-published potential link between allergy 
and childhood infection, especially with Helicobacter pylori.12–14
Until the late 1980s, interest in the role of infections in allergic diseases focused 
principally upon the process of primary allergic sensitization. The literature of the 
time contained several observations which argued for a role for infections, including 
the ability of bacterial-derived immunostimulants such as pertussigen to selectively 
improve priming for immunoglobulin (Ig)E antibody production,15 and the potential of 
lipopolysaccharide to bypass tolerance to mucosally applied allergens. Also, other studies 
reported that respiratory viral infections such as influenza could subvert the generation 
of protective “inhalation tolerance” to aeroallergens.16 More recently, signals such as 
enterotoxins from skin-dwelling bacteria have been invoked as important contributors to 
the pathogenesis of atopic dermatitis.17 However, it was also clear from other observations 
that microbial exposure per se could not be considered in generic terms as “pro-atopic”. 
For example, other microbial-derived agents exemplified by the components of Freund’s 
adjuvant displayed atopy-antagonistic activity,18 and stimuli derived from normal gut flora 
were demonstrated to be necessary to facilitate the expression of oral tolerance to fed Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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allergens,19 and also inhalation tolerance to aeroallergens.20 
These observations suggested that microbial-derived stimuli 
had potential to modulate the etiology and pathogenesis of 
atopic diseases in dichotomous ways, their ultimate effects 
perhaps being context-dependent.
In this review we will focus our attention on the unambiguous 
effects of H. pylori on asthma and atopy.
The role of Helicobacter pylori  
in asthma and allergy
H. pylori, a Gram-negative bacillus that colonizes the human 
stomach, is the main cause of peptic ulceration, gastric 
lymphoma, and gastric adenocarcinoma, the second leading 
cause of death from cancer worldwide. The World Health 
Organization classifies H. pylori as a human carcinogen 
for distal gastric cancer, and eradicating the bacterium in 
high risk populations reduces incidence of gastric cancer.21 
H. pylori also may contribute to other conditions, including 
iron and vitamin B12 deficiencies, idiopathic thrombocy-
topenic purpura, and growth retardation in children. H. pylori 
colonization occurs in childhood and persists throughout life, 
causing disease mainly in adults.22,23
In 1989, Strachan proposed the “hygiene hypothesis”, 
stating that the exposure to infectious agents and living in 
an unhygienic environment might “educate” the immune 
system and thus protect against the development of allergic 
diseases.24 The idea originated from epidemiological obser-
vations suggesting a general hypothesis that infections in 
early childhood acquired from older siblings might confer 
protection against the development of atopic diseases such 
as atopic eczema, allergic rhinoconjunctivitis, and asthma. 
Subsequent research into the association between childhood 
infections and atopic sensitization or atopic disease have 
offered conflicting results. Indeed, our understanding of the 
timing, the mechanism, and the specific infections that might 
carry antiallergenic potential are by no means satisfactory.25,26 
The T helper (Th)-1/Th-2 paradigm of adaptive immune 
responses provided the initial immunological backbone for 
the hygiene hypothesis.27–29 On the basis of the cytokine 
production patterns, T cell responses may be divided into 
counter-regulatory Th-1 and Th-2 subtypes. Th-2 responder 
phenotype is associated with atopic sensitization and atopic 
disease. Indeed, inflammation of the Th-2 type appears to 
be active in the initial stage of the pathogenesis of atopic 
eczema,30,31 allergic rhinoconjunctivitis,32,33 and asthma.34,35
In detail, the histopathological characteristics of bronchial 
asthma, even a mild one, are represented by inflammatory 
infiltrates consisting of T lymphocytes and accumulation 
of activated eosinophils, epithelial shedding, and basal 
membrane thickening. Immunological and molecular studies 
of bronchial biopsies and bronchoalveolar lavage samples 
obtained in baseline disease or taken after natural or “experi-
mentally” induced asthma exacerbations have shown that a 
complex and fascinating inflammatory mechanism sustains 
the pathogenesis of bronchial asthma, including the partici-
pation of different types of Th cells and peculiar cytokine 
and chemokine networks.36 In allergic asthmatic patients, 
allergen exposure induces a predominant activation of Th-2 
lymphocytes in the airways, able to over-express several 
Th-2 cytokines, such as interleukin (IL)-4 and IL-5.34,37 
Moreover, the degree of IL-5 expression at the bronchial 
level is associated with the disease severity both in atopic 
and in nonatopic asthma.38 IL-5 and granulocyte macrophage 
colony-stimulating factor (GM-CSF) can be considered 
the most important cytokines for eosinophil accumulation 
in asthmatic inflammation. Th-2 cytokines in bronchial 
asthma are produced not only by CD4+ but also by CD8+ T 
cells, which contribute to the genesis of asthma and to the 
clinical expression of the disease.39 In H. pylori infection, a 
predominant activation of Th-1 cells, with the production of 
interferon (IFN)-γ, IL-12, IL-18, IL-23, and tumor necrosis 
factor (TNF)-α, occurs in vivo in the stomach of humans 
and in animal models, and the inhibition of the allergic 
Th-2 inflammation by Th-1 responses can explain the inverse 
relationship between H. pylori and asthma.40
Mechanism of action  
of Helicobacter pylori
H. pylori colonizes the human stomach in childhood and 
persists for decades.23 This implies near perfect adaptation 
to the niche and an ability to evade the human immune 
response. Its spiral shape and flagella allow it to corkscrew 
through the gastric mucus gel, and numerous adhesins enable 
selective adherence to the epithelium. H. pylori has multiple 
mechanisms for protection against gastric acid;41 notably, 
15% of its protein content comprises preformed cytoplasmic 
urease that, when the external pH is less than 6.5, neutralizes 
the periplasm, allowing maintenance of the cytoplasmic 
membrane potential.42
Like many human commensal bacteria, H. pylori has 
evolved specific mechanisms to avoid stimulating the immune 
response. For example, innate immune recognition by several 
Toll-like receptors (TLRs) is attenuated for H. pylori.43,44 
Despite this, colonization is associated with inflammatory 
and mucosa infiltration of polymorphonuclear leukocytes, 
macrophages, and Th-1 lymphocytes, with active production Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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of IL-12 and IFN-γ.45 Such an immune response is expected 
to play a role in the pathogenesis of H. pylori-associated dis-
eases in humans.45,46 Accordingly, a Th-1-directed immune 
response, induced by H. pylori infection, increases gastric 
inflammation and atrophy, whereas Th-2 redirection reduces 
them.47,48 Different pathways are responsible for the predomi-
nant H. pylori-induced mucosal Th-1 response.45,46 Stimula-
tion of human neutrophils, monocytes, and dendritic cells with 
H. pylori neutrophil-activating protein (HP-NAP) strongly 
upregulates both IL-12 and IL-23 production, via TLR2 acti-
vation. In the gastric mucosa of H. pylori-infected patients, 
a considerable proportion of Th cells is specific for different 
H. pylori antigens, including HP-NAP, CagA, urease, VacA, 
and heat shock proteins, and HP-NAP drives the production 
of high levels of IFN-γ and TNF-α by gastric Th cells, thus 
promoting a polarized Th-1 response (Figure 1).45–49
Protective properties  
of Helicobacter pylori  
on asthma and allergies
Asthma, a chronic inflammatory disease of the airways 
is a multifaceted disorder characterized by airway hyper-
responsiveness to a multiplicity of specific and nonspecific 
stimuli, and mucus hypersecretion by goblet cells.
The severity and incidence of asthma have increased 
drastically in the developed nations over recent decades. 
Although the underlying reason is still unknown, clinical, 
epidemiological, and experimental evidence indicate that 
infectious diseases can influence the development of allergic 
disorders.24 Accordingly, an inverse correlation has been 
demonstrated between the onset of allergic disorders and the 
incidence of infections. This may be the result of an inhibition 
of allergic Th-2 inflammation exerted by Th-1 responses; the 
latter are elicited by infectious agents and are able to induce 
the production of IFN-γ, IL-12, IL-18, and IL-23.50 This 
view is supported by studies showing that development of 
asthma can be prevented in animals by administering live 
or killed bacteria or their components, which induce Th-1 
responses.51 Also, we demonstrated that H. pylori inhibited 
Th-2 responses in asthmatic patients.49 Interestingly, on the 
basis of large epidemiological studies, recently, a consistent 
negative association between H. pylori infection and the 
presence of allergic disorders, such as asthma and rhinitis, 
has been proposed.52 Table 1 summarizes some recent studies 
in which the relationships of H. pylori with asthma, atopy, 
allergic rhinitis, and/or eczema were examined.2,8,53–60 In 
general, the cross-sectional studies, involving a variety of 
populations and somewhat differing definitions of atopy 
and asthma, show significant inverse relationships of these 
conditions with H. pylori. The published case-control studies, 
in general much smaller in scale, do not show any significant 
direct or inverse relationships.
Although it is an undoubtedly interesting theory, no con-
vincing molecular mechanism has been proposed to support it. 
Our studies, carried out with H. pylori may help in understand-
ing this complex issue. We have shown that addition of HP-
NAP (a dodecamer formed by four-helix bundled subunits with 
a hollow central part) to allergen-induced T-cell lines derived 
from allergic asthmatic patients led to a drastic increase in IFN-
γ-producing T cells and to a decrease in IL-4-secreting cells, 
thus resulting in a redirection of the immune response from a 
Th-2 to a Th-1 phenotype.49 Furthermore, in the gastric mucosa 
of H. pylori-infected patients a remarkable proportion of Th 
cells showed significant proliferation to different H. pylori 
antigens, including HP-NAP; upon HP-NAP stimulation, 
Ag-specific gastric Th cells produced large amounts of IFN-γ 
and TNF-α, and displayed a powerful cytotoxic activity, thus 
showing a polarizing Th-1 effector phenotype.
Likewise, HP-NAP stimulation of neutrophils, monocytes, 
and dendritic cells resulted in a remarkable upregulation of 
cytokines, including IL-12 and IL-23, contributing to the 
induction of an IL-12- and IL-23-enriched milieu, which has 
the potential to drive the differentiation of antigen-stimulated 
T cells towards a polarized Th-1 phenotype (Figure 1).56,61
An issue to be considered in studies showing negative 
associations between H. pylori and various atopic and 
allergic diseases is that H. pylori positivity is linked with 
more crowded living conditions and poor hygiene in infancy. 
Since these factors also are associated with other childhood 
infections, H. pylori status may simply be a marker for these. 
However, the negative association with childhood asthma is 
stronger for cagA+ H. pylori strains.56
Another hypothetical explanation for the inverse 
association between H. pylori and asthma is that the high 
levels of regulatory T cells (Tregs) associated with H. pylori 
infection may contribute to prevention of allergic diseases, 
and H. pylori-free humans are thus more susceptible to 
these diseases (Figure 2). In support of this, H. pylori-
positive people have higher levels of gastric Tregs than 
those without the organism,62,63 and more importantly also, 
circulating Tregs are increased in number.64 In addition, in 
mice experimentally infected with H. pylori, systemic Tregs 
are increased, and these suppress other immune responses, 
one effect of which is to facilitate H. pylori colonization.65 
The excess Tregs may have immunosuppressive activity in 
humans as well: among H. pylori-positive persons, those Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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with fewer Tregs are more likely to have peptic ulcers62 
and so presumably have more intense gastritis. Finally, in 
cagA+ H. pylori colonization, mucosal Tregs may be more 
numerous, and mucosal levels of the immunomodulatory 
cytokine IL-10 may be higher than in cagA– colonization.66 
If the same phenomenon applies to circulating Tregs, it could 
potentially explain the stronger, negative association with 
childhood asthma of cagA+ strains.56 Taken together, these 
studies imply a theoretical plausible link between H. pylori, 
Tregs, and reduction in risk of allergic diseases. However, 
interventional studies in relevant animal models and in 
humans are needed to verify the hypothesis.
Effect on immune system  
and lung function
So far we have considered what happens in the stomach and 
at the systemic level, following H. pylori colonization; but 
a very pertinent question about the link between asthma and 
H. pylori is whether H. pylori may have some effects in the 
lung region. To answer this question we created a mouse 
CagA VacA
HP-NAP
Urease HSP
Neutrophils Monocytes
macrophages
IL-12I L-23
Th1
cells Th2
cells
TNF-α IFN-γ
Helicobacter pylori
Figure 1 Schematic representation of Helicobacter pylori-driven inhibition of allergic Th-2 inflammation via activation of Th-1 responses. Following H. pylori infection, HP-NAP 
and other H. pylori factors induce the production of iL-12 and iL-23 that both promote the preferential development of Th-1 cells and repress the Th-2 allergic response. 
Abbreviations: HP-NAP, H. pylori neutrophil-activating protein; Th, T helper; iL, interleukin; iFN, interferon; TFN, tumor necrosis factor.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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model of allergic asthma,67 and demonstrated that in vivo 
administration of HP-NAP prevents the typical eosinophil 
accumulation in the lung, as well as the increase of serum 
IgE. These results suggest the possibility that HP-NAP might 
be a part of the molecular mechanism underlying the negative 
association between H. pylori infection and allergy, cor-
roborating the epidemiological observations with a plausible 
scientific explanation. To address whether HP-NAP, on the 
basis of its immune-modulating activity, could be beneficial 
for the prevention and treatment of bronchial asthma, it was 
administered via the intraperitoneal or the intranasal route 
using a mouse model of allergic asthma induced by inhaled 
ovalbumin (OVA). Groups of nine C57BL/6j, wild type or 
tlr2−/−, mice were treated with OVA alone, or with OVA plus 
HP-NAP intraperitoneally or mucosally administered. In 
both systemic and mucosal protocols, mice were treated with 
OVA according to a standardized procedure consisting of a 
first phase of sensitization with OVA intraperitoneally and 
a second phase of induction of the allergic response with 
aerosolized OVA on day 8, followed by repeated aerosol chal-
lenge with the allergen on days 15–18. Control animals were 
injected with phosphate-buffered saline (PBS) alone and then 
exposed to aerosolized PBS. In the systemic protocol, mice 
were treated with intraperitoneal HP-NAP on day 1, whereas 
in the mucosal protocol mice received intranasal HP-NAP on 
days 7 and 8.67 After priming and a repeated aerosol challenge 
with OVA, Th-2 responses were induced in the mouse lung. 
Accordingly, following OVA treatment, eosinophils were 
recruited and activated in bronchial airways, and serum IgE 
levels increased. Both systemic and mucosal administration 
of HP-NAP strongly inhibited the development of airway 
eosinophilia and bronchial inflammation. Likewise, HP-NAP 
treatment strongly affected the lung cytokine release, reduc-
ing the production of IL-4, IL-5, and GM-CSF. Systemic 
HP-NAP also significantly resulted in both the reduction 
of total serum IgE and an increase of IL-12 plasma levels. 
Table 1 Major studies showing a negative association between Helicobacter pylori and asthma/atopic diseases
Location/type of study Study population H. pylori detection Clinical and laboratory findings  
of the atopic patients studied
Reference
Japan/C-C 46 patients with 
asthma/48 HC
igG eLiSA  
igG CagA
Current asthma diagnosed  
by ATS guidelines.
53
Scotland/C-C 97 patients/208 C igG eLiSA Skin and specific IgE tests.  
Atopy: weal $ 3 mm, or any  
ige . 0.35 iU/mL.  
Self-reported adult-onset  
wheeze and asthma.
8
italy/C-C 240 atopic patients/ 
240 nonatopic C
igG eLiSA Total ige.  
Atopy: logRU . 1.2. 
Nonatopic , logRU , 0.
2
Hong Kong/C-C 90 patients with  
asthma/97 C
igG eLiSA Current asthma diagnosed  
by ATS guidelines.
54
UK/C-S 3244 patients 13C-urea  
breath test
Asthma (treated with inhalers),  
allergic rhinitis (treated with  
antihistamines), and  
eczema (treated with  
topical corticosteroids).
55
USA/C-S 7663 atopic adults igG eLiSA  
igG CagA
Self-reported asthma and hay fever  
(current and lifetime).  
Skin sensitization tests.
56
Finland, Russian/C-S 1177 patients igG elisa Skin prick testing with a panel  
of 11 common airborne allergens.  
Atopy: any wheal diameter $ 3 mm.
57
Germany/C-S 321 with blood samples 
from 930 randomly  
selected from 3112 
inhabitants
igG eLiSA  
igG CagA
Specific IgE against a panel of  
aeroallergens. 
Atopy: any ige . 0.70 kU/L.
58
Denmark/C-S 1011 patients igG eLiSA Self-reported allergic rhinitis.  
Specific IgE to 6 allergens.  
Atopy: any ige . 0.35 kU/L.
59
iceland, Sweden,  
estonia/C-S
1249 patients igG eLiSA Detection of specific atopy: any  
ige . 0.35 kU/L.
60
Abbreviations: ATS, American Thoracic Society; C-C, case-control; C-S, cross-sectional; C, controls; HC, healthy controls; ig, immunoglobulin; eLiSA, enzyme-linked-
immunosorbent serologic assay test.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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However, no suppression of lung eosinophilia and bronchial 
Th-2 cytokines was observed in TLR2 knock-out mice fol-
lowing treatment with the TLR2 ligand HP-NAP.67 The results 
obtained in our studies suggest that HP-NAP might be the key 
element responsible for the decrement of allergy frequency 
in H. pylori-infected patients.
Conclusion
H. pylori and humans have coevolved for at least 50,000 
years and probably for much longer. As such, H. pylori 
colonization has been essentially universal, and the usual 
pattern of inflammation has likely been pan-gastric. H. pylori 
is the main cause of peptic ulceration, gastric lymphoma, 
and gastric adenocarcinoma.
The loss of this ancient, dominant, and persistent member 
of the normal biota of humans would be predicted to have 
consequences, and now there is much information about the 
beneficial and deleterious aspects of this change on the health 
and disease of the gastrointestinal tract. However, increasing 
evidence is pointing to extra-intestinal manifestations of the 
Treg
Th1
cells Th2
cells
Helicobacter 
pylori
Figure 2 inhibition of Th-2 response might hypothetically occur by Helicobacter pylori-induced activation of regulatory T cells.
Abbreviations: Th, T helper; Treg, regulatory T cell.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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disappearance of H. pylori, including asthma. An inverse 
association of H. pylori and childhood asthma, allergic 
rhinitis, and atopy is becoming increasingly obvious.
This phenomenon might be explained by the inhibition 
of the allergic Th-2 inflammation by the Tregs that could be 
present during H. pylori infection and could suppress the 
atopy-associated Th-2 response.
However, a realistic hypothesis, based on clinical and 
experimental evidence in humans and animal models,45,49,67 
is that the allergic Th-2 response is redirected by the Th-1 
response elicited by H. pylori, that is able to induce the 
production of IFN-γ, IL-12, IL-18, and IL-23. Several 
studies were devoted to the definition of new immune 
modulating factors able to inhibit Th-2 responses, and dif-
ferent compounds have been proposed for the treatment 
and prevention of asthma and atopic diseases, including 
several TLR ligands mimicking the effects of microbial 
components such as dsRNA, CpG-oligodeoxynucleotides, 
and imidazoquinolines.68–70 In detail, it has been shown that 
HP-NAP, by acting on both neutrophils and monocytes fol-
lowing the engagement of TLR2, significantly contributes to 
create an IL-12- and IL-23-enriched milieu, and as such it 
represents a key bacterial factor able to drive the differentia-
tion of antigen-stimulated T cells toward a polarized Th-1 
phenotype. HP-NAP has the potential to redirect the in vitro 
allergen-specific T-cell response from a predominant Th-2 
to a Th-1 response. Also, HP-NAP administration in vivo 
resulted in inhibition of the typical Th-2-mediated bronchial 
inflammation of allergic bronchial asthma. Thus, altogether, 
these results support the view that the increased prevalence 
and severity of asthma and allergy in Western countries may 
be related, at least in part, to the decline of H. pylori infection, 
which is able to induce a long-lasting Th-1 background, and 
suggest also that H. pylori compounds such as HP-NAP could 
be important candidates for novel strategies of the prevention 
and treatment of asthma and allergic diseases.
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